A sero survey conducted in Kashmir has found that two out of every five people in the valley have developed antibodies against the coronavirus. The survey carried out in October found the highest prevalence of antibodies in Pulwama at 43.1 per cent and the lowest in Kulgam at 28.5 per cent, news agency PTI reported.
Meanwhile, the Union Home Ministry has announced a slew of measures to aid the Covid-19 situation in the national capital, including conducting a house to house survey; deploying mobile testing vans; flying in more doctors and paramedics; increasing ICU beds, ventilators and BIPAP machines; and placing more equipment in private sector labs.
At the same time, India, as a whole, detected 38,617 cases and 474 deaths in the 24 hours ending 9 am Wednesday, taking the country’s overall coronavirus caseload to 89.12 lakh. India’s 89,12,908 cases includes 4,46,805 active cases, 83,35,110 recoveries and 1,30,993 deaths.
Prime Minister Narendra Modi spoke to US President-elect Joe Biden Tuesday night, the first phone conversation between the leaders since the latter won the American presidential elections. PM Modi and Biden discussed their shared priorities and concerns over the Covid-19 pandemic, among other things.
With several vaccines for the novel coronavirus in late-stage clinical trials, the Indian government is strategising their distribution. On Monday, Dr V K Paul, member, NITI Aayog, who heads the high-level national expert group on vaccine administration, said the government was relying on the five candidates being clinically tested in India. This is because, he said, candidates like Pfizer and Moderna are yet to be granted licences in India, and are likely to first be delivered to countries that have already signed deals with these firms. The doses are likely to arrive in India months later. Paul said the candidates being tested locally will be able to fulfill the large domestic requirements.x